Jorda MA et al. |
Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2. |
2003 |
Ann. N. Y. Acad. Sci. |
pmid:12799277
|
Walter L and Stella N |
Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes. |
2003 |
Glia |
pmid:12951660
|
Wallace MJ et al. |
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12954810
|
Vannacci A et al. |
Nitric oxide modulates the inhibitory effect of cannabinoids on the immunological activation of guinea pig mast cells. |
2003 |
Inflamm. Res. |
pmid:12755386
|
Kishimoto S et al. |
2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. |
2003 |
J. Biol. Chem. |
pmid:12711605
|
Maccarrone M et al. |
Activation of human platelets by 2-arachidonoylglycerol is enhanced by serotonin. |
2003 |
Thromb. Haemost. |
pmid:12574815
|
Walter L et al. |
Nonpsychotropic cannabinoid receptors regulate microglial cell migration. |
2003 |
J. Neurosci. |
pmid:12598628
|
Fride E et al. |
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor. |
2003 |
Eur. J. Pharmacol. |
pmid:12568912
|
Higgs S et al. |
Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. |
2003 |
Psychopharmacology (Berl.) |
pmid:12447606
|
Bisogno T et al. |
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. |
2003 |
J. Cell Biol. |
pmid:14610053
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|
Högestätt ED and Zygmunt PM |
Cardiovascular pharmacology of anandamide. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052048
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Kozak KR et al. |
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. |
2002 |
J. Biol. Chem. |
pmid:12244105
|
Mechoulam R et al. |
Cannabinoids and brain injury: therapeutic implications. |
2002 |
Trends Mol Med |
pmid:11815270
|
Gubellini P et al. |
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. |
2002 |
J. Neurosci. |
pmid:12177188
|
Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|